Public Comments to Agencies
FDA Comments Supporting Tobacco Harm Reduction Products
August 10, 2017 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852
Supporting the Petitions for Reconsideration of the FCC's Privacy Order
BEFORE THE FEDERAL COMMUNICATIONS COMMISSION Washington, D.C. In the Matter of ) )
Reply Comments Regarding the FCC's Privacy Rules
BEFORE THE FEDERAL COMMUNICATIONS COMMISSION Washington, D.C. In the Matter of Protecting the Privacy of Customers of Broadband and Other Telecommunications Services WC Docket No. 16-106 Reply Comments of
Comments to FDA on Labeling for Biosimilar Products
May 31, 2016 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852. Re: Docket No. FDA-2016-D-0643 “Labeling for Biosimilar Products; Draft Guidance for Industry”
FCC Comments on Protecting the Privacy of Customers of Broadband and Other Telecommunications Services
[PDF Download]
Public Comments on FCC AllVid Proposal
Sections: [Introduction] | [Government Technology Mandates] [Market Competition] | [Abrogation of Intellectual Property Rights]
Comments to the FCC regarding the Regulatory Status of Mobile Messaging Services (WT Docket No. 08-7)
Before the FEDERAL COMMUNICATIONS COMMISSION Washington, D.C. 20554 In the matter of Petition of Twilio, Inc., Seeking a Declaratory Ruling Clarifying the Regulatory Status of Mobile Messaging Services )
